Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Khusru Asadullah"'
Autor:
Kristian Reich, Kilian Eyerich, Knut Schäkel, Peter Weisenseel, Andreas Pinter, Khusru Asadullah, Sven Wegner, Ernesto J Muñoz-Elias, Holger Bartz, Friedmann J H Taut
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Background Guselkumab is an interleukin (IL)-23 pathway blocker with proven efficacy in patients with moderate-to-severe plaque psoriasis. Early intervention with guselkumab may result in changes to the clinical disease course versus later interventi
Externí odkaz:
https://doaj.org/article/673be33cf2a54e4aba93d38bcb985891
Autor:
Matthias, Augustin, Lilla, Landeck, Sebastian, Diemert, Khusru, Asadullah, Urte, Hammann, Konstantin, Ertner, Ina, Hadshiew
Publikováno v:
Dermatology and Therapy. 12:1121-1131
Dimethyl fumarate (DMF) is an oral compound to treat plaque psoriasis. Data on the treatment of patients with psoriasis affecting impactful areas are scarce. In this interim analysis of the prospective, noninterventional SKILL study, we summarized re
Autor:
K Eyerich, Nenja Krüger, Yvonne Personke, Sven Wegner, Mario Gomez, Peter Weisenseel, Carle Paul, Andreas Pinter, Khusru Asadullah, Knut Schäkel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d6301c67cd85988539841ca098047ed
https://doi.org/10.26226/m.62fa009023ef91001a663bc5
https://doi.org/10.26226/m.62fa009023ef91001a663bc5
Autor:
F. Lauffer, Wolf-Henning Boehncke, Stefan Beissert, Khusru Asadullah, Kilian Eyerich, Michael P. Schön, Kamran Ghoreschi
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 18:675-681
Verschiedene Immunzellen und ihre Botenstoffe beeinflussen die Pathogenese der Psoriasis. Den Zytokinen der IL-17-Familie kommt dabei eine besondere Bedeutung zu. Neben IL-17A, das eine zentrale Rolle bei der Pathogenese der Psoriasis spielt, wirken
Autor:
Khusru Asadullah, Andreas Pinter, Kilian Eyerich, Friedmann J H Taut, Holger Bartz, Ernesto J. Muñoz-Elías, Sven Wegner, Knut Schäkel, Peter Weisenseel, Kristian Reich
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
BackgroundGuselkumab is an interleukin (IL)-23 pathway blocker with proven efficacy in patients with moderate-to-severe plaque psoriasis. Early intervention with guselkumab may result in changes to the clinical disease course versus later interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0ee3a8ed6c7a530b558e9f07a8901c
http://publikationen.ub.uni-frankfurt.de/files/63018/e049822_full.pdf
http://publikationen.ub.uni-frankfurt.de/files/63018/e049822_full.pdf
Autor:
Knut Schäkel, Kristian Reich, Khusru Asadullah, Andreas Pinter, Denis Jullien, Peter Weisenseel, Carle Paul, Mario Gomez, Sven Wegner, Yvonne Personke, Kilian Eyerich
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB195
Autor:
Kamran Ghoreschi, Katja Fuhrmeister, Xiao Yong Man, Ernesto Gonzalez-Martinez, Robert Sabat, Khusru Asadullah, Lilla Landeck
Publikováno v:
Immunotherapy. 13(7)
Over the past two decades, significant progress has been achieved in the treatment of psoriasis by targeting the human cytokine network. At present, 11 biologicals – antibodies, and a soluble receptor – are used to neutralize key inflammatory cyt
Autor:
F. Lauffer, Wolf-Henning Boehncke, Kilian Eyerich, Michael P. Schön, Kamran Ghoreschi, Khusru Asadullah, Stefan Beissert
Various immune cells and their messenger substances influence the development of psoriasis. Cytokines of the IL-17 family are of particular importance. In addition to IL-17A, which plays a central role in the pathogenesis of psoriasis, other subtypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc3bfa15b9b554f5971040995474f7e
https://mediatum.ub.tum.de/doc/1580128/document.pdf
https://mediatum.ub.tum.de/doc/1580128/document.pdf
Publikováno v:
Archives of Dermatological Research
Fumarates (fumaric acid esters, FAEs) are orally administered systemic agents used for the treatment of psoriasis and multiple sclerosis. In 1994, a proprietary combination of FAEs was licensed for psoriasis by the German Drug Administration for use
Publikováno v:
Der Deutsche Dermatologe. 66:371-373